These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 3712031)
1. The effects of HA compound calcium antagonists on delayed cerebral vasospasm in dogs. Takayasu M; Suzuki Y; Shibuya M; Asano T; Kanamori M; Okada T; Kageyama N; Hidaka H J Neurosurg; 1986 Jul; 65(1):80-5. PubMed ID: 3712031 [TBL] [Abstract][Full Text] [Related]
2. The effects of an intracellular calcium antagonist HA 1077 on delayed cerebral vasospasm in dogs. Shibuya M; Suzuki Y; Takayasu M; Asano T; Harada T; Ikegaki I; Satoh S; Hidaka H Acta Neurochir (Wien); 1988; 90(1-2):53-9. PubMed ID: 3344625 [TBL] [Abstract][Full Text] [Related]
3. Mechanism of action of a novel antivasospasm drug, HA1077. Asano T; Ikegaki I; Satoh S; Suzuki Y; Shibuya M; Takayasu M; Hidaka H J Pharmacol Exp Ther; 1987 Jun; 241(3):1033-40. PubMed ID: 3598899 [TBL] [Abstract][Full Text] [Related]
4. Endothelin and the production of cerebral vasospasm in dogs. Asano T; Ikegaki I; Suzuki Y; Satoh S; Shibuya M Biochem Biophys Res Commun; 1989 Mar; 159(3):1345-51. PubMed ID: 2649099 [TBL] [Abstract][Full Text] [Related]
5. Possible role of protein kinase C-dependent smooth muscle contraction in the pathogenesis of chronic cerebral vasospasm. Matsui T; Takuwa Y; Johshita H; Yamashita K; Asano T J Cereb Blood Flow Metab; 1991 Jan; 11(1):143-9. PubMed ID: 1983998 [TBL] [Abstract][Full Text] [Related]
6. The role of active smooth-muscle contraction in the occurrence of chronic vasospasm in the canine two-hemorrhage model. Matsui T; Kaizu H; Itoh S; Asano T J Neurosurg; 1994 Feb; 80(2):276-82. PubMed ID: 8283267 [TBL] [Abstract][Full Text] [Related]
7. Possible prophylactic potential of HA1077, a Ca2+ channel antagonist and vasodilator, on chronic cerebral vasospasm. Satoh S; Suzuki Y; Harada T; Ikegaki I; Asano T; Shibuya M; Sugita K; Hidaka H Eur J Pharmacol; 1992 Sep; 220(2-3):243-8. PubMed ID: 1425995 [TBL] [Abstract][Full Text] [Related]
8. Effects of inhibitors of protein kinase C and calpain in experimental delayed cerebral vasospasm. Minami N; Tani E; Maeda Y; Yamaura I; Fukami M J Neurosurg; 1992 Jan; 76(1):111-8. PubMed ID: 1370069 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological and morphological effects of in vitro transluminal balloon angioplasty on normal and vasospastic canine basilar arteries. Chan PD; Findlay JM; Vollrath B; Cook DA; Grace M; Chen MH; Ashforth RA J Neurosurg; 1995 Sep; 83(3):522-30. PubMed ID: 7666232 [TBL] [Abstract][Full Text] [Related]
10. Endothelin: a potential modulator of cerebral vasospasm. Asano T; Ikegaki I; Satoh S; Suzuki Y; Shibuya M; Sugita K; Hidaka H Eur J Pharmacol; 1990 Nov; 190(3):365-72. PubMed ID: 2272374 [TBL] [Abstract][Full Text] [Related]
11. Alterations in endothelium-dependent responsiveness of the canine basilar artery subarachnoid hemorrhage. Kim P; Sundt TM; Vanhoutte PM J Neurosurg; 1988 Aug; 69(2):239-46. PubMed ID: 3134520 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of intrathecal liposomal fasudil for experimental cerebral vasospasm after subarachnoid hemorrhage. Takanashi Y; Ishida T; Meguro T; Kiwada H; Zhang JH; Yamamoto I Neurosurgery; 2001 Apr; 48(4):894-900; discussion 900-1. PubMed ID: 11322450 [TBL] [Abstract][Full Text] [Related]
13. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog. Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852 [TBL] [Abstract][Full Text] [Related]
14. Effect of endothelinA-receptor antagonist BQ-123 and phosphoramidon on cerebral vasospasm. Cosentino F; McMahon EG; Carter JS; Katusić ZS J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S332-5. PubMed ID: 7509979 [TBL] [Abstract][Full Text] [Related]
15. Thromboxane A2 synthetase inhibitor failed to ameliorate the arterial narrowing during the chronic phase of cerebral vasospasm. Toshima Y; Satoh S; Ikegaki I; Asano T; Suzuki Y; Shibuya M Life Sci; 1997; 61(14):1371-7. PubMed ID: 9335226 [TBL] [Abstract][Full Text] [Related]
16. Activation of the protein kinase C-mediated contractile system in canine basilar artery undergoing chronic vasospasm. Matsui T; Sugawa M; Johshita H; Takuwa Y; Asano T Stroke; 1991 Sep; 22(9):1183-7. PubMed ID: 1926262 [TBL] [Abstract][Full Text] [Related]
17. Combined effect of L-arginine and superoxide dismutase on the spastic basilar artery after subarachnoid hemorrhage in dogs. Kajita Y; Suzuki Y; Oyama H; Tanazawa T; Takayasu M; Shibuya M; Sugita K J Neurosurg; 1994 Mar; 80(3):476-83. PubMed ID: 8113861 [TBL] [Abstract][Full Text] [Related]
18. Optimal cerebrospinal fluid magnesium ion concentration for vasodilatory effect and duration after intracisternal injection of magnesium sulfate solution in a canine subarachnoid hemorrhage model. Mori K; Yamamoto T; Miyazaki M; Hara Y; Aiko Y; Koike N; Sakamoto S; Nakao Y; Esaki T J Neurosurg; 2011 Apr; 114(4):1168-75. PubMed ID: 21073257 [TBL] [Abstract][Full Text] [Related]
19. The effect of nicardipine on vasospasm in rabbit basilar artery after subarachnoid hemorrhage. Pasqualin A; Vollmer DG; Marron JA; Tsukahara T; Kassell NF; Torner JC Neurosurgery; 1991 Aug; 29(2):183-8. PubMed ID: 1886655 [TBL] [Abstract][Full Text] [Related]
20. Effects of the Ca++-permeable nonselective cation channel blocker LOE 908 on subarachnoid hemorrhage-induced vasospasm in the basilar artery in rabbits. Kawanabe Y; Masaki T; Hashimoto N J Neurosurg; 2003 Mar; 98(3):561-4. PubMed ID: 12650428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]